Erratum: Early antiretroviral treatment reduces risk of bacille Calmette- Guérin immune reconstitution adenitis (International Journal of Tuberculosis and Lung Disease (2011) 15, 19 (1194 -1200) DOI: 10.5588/ijtld.10.0721);Early antiretroviral treatment reduces risk of bacille Calmette- Guérin immune reconstitution adenitis

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 9, 2011, Pages 1194-1200

  Rabie, H ^a   Violari, A ^b   Duong, T ^c   Madhi, S A ^b   Josipovic, D ^b   Innes, S ^a   Dobbels, E ^a   Lazarus, E ^b   Panchia, R ^b   Babiker, A G ^d   Gibb, D M ^d   Cotton, M F ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

BCG; Immune reconstitution infl ammatory syndrome; Paediatric HIV

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; VIRUS RNA;

ARTICLE; BCG VACCINATION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; EARLY INTERVENTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFANT; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SOUTH AFRICA; TREATMENT PLANNING; VIRUS LOAD;

EID: 80051676494     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0721-e     Document Type: Erratum

References (27)

1. Bhat G J, Diwan V K, Chintu C, et al. HIV, BCG and TB in children: a case control study in Lusaka, Zambia. J Trop Pediatr 1993; 39: 219-223. (Pubitemid 23241421)
2. Mansoor N, Scriba T J, de Kock M, et al. HIV-1 infection in infants severely impairs the immune response induced by bacille Calmette-Guerin vaccine. J Infect Dis 2009; 199: 982-990.
3. Trunz B B, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367: 1173-1180.
4. Azzopardi P, Bennett C M, Graham S M, Duke T. Bacille C almette-Guérin vaccine-related disease in HIV-infected children: a systematic review. Int J Tuberc Lung Dis 2009; 13: 1331-1344.
5. Revised BCG vaccination guidelines for infants at risk for HIV infection. Wkly Epidemiol Rec 2007; 82: 193-196.
6. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. Geneva, Switzerland: WHO, 2007. www.who.int/hiv/topics/ paediatric/en/ index.html Accessed June 2011.
7. Joint United Nations Programme on HIV/AIDS. Third stocktaking report on children and AIDS. Geneva, Switzerland: UNAIDS, 2008. http://data.unaids.org/ pub/Report/2008/2008 1201-3rd-stocktaking-en.pdf Accessed June 2011.
8. Cotton M F, Schaaf H S, Lottering G, et al. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 2008; 12: 225-227. (Pubitemid 351212418)
9. Hesseling A C, Cotton M F, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48: 108-114.
10. Bannister C, Bennett L, Carville A, et al. Evidence behind the WHO guidelines: hospital care for children: what is the evidence that BCG vaccination should not be used in HIV-infected children? J Trop Pediatrics 2008; 55: 78-82.
11. Hesseling A C, Rabie H, Marais B J, et al. Bacille Calmette- Guerin vaccine-induced disease in HIV-infected and HIVuninfected children. Clin Infect Dis 2006; 42: 548-558. (Pubitemid 43202529)
12. Smith K, Kuhn L, Coovadia A, Meyers T. Immune reconstitution infl ammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS 2009; 23: 1097-1107.
13. Boulware D R, Callens S, Pahwa S. Pediatric HIV immune reconstitution infl ammatory syndrome. Curr Opin HIV AIDS 2008; 3: 461-467.
14. Nuttall J J, Davies M, Hussey G, et al. Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy. Int J Infect Dis 2008; 12: e99-e105.
15. Puthanakit T, Oberdorfer P, Punjaisee S, et al. Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection. Clin Infect Dis 2005; 41: 1049-1052. (Pubitemid 41368232)
16. Violari A, Cotton M, Gibb D M, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359: 2233-2244.
17. World Health Organization. WHO case defi nitions of HIV for surveillance and revised clinical staging and immunological classifi cation for HIV-related disease in adults and children. Geneva, Switzerland: WHO, 2007. www.who.int/hiv/pub/guidelines/ HIVstaging150307.pdf Accessed June 2011.
18. Kuczmarski R J, Ogden C L, Guo S S, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002; 246: 1-190.
19. Wade A M, Ades A E. Incorporating correlations between measurements into the estimation of age-related reference ranges. Stat Med 1998; 17: 1989-2002. (Pubitemid 28425262)
20. European Collaborative Study. Are there gender and race differences in cellular immunity patterns over age in infected and uninfected children born to HIV-infected women? J Acquir Immune Defi c Syndr 2003; 33: 635-641.
21. Gray L, Cortina-Borja M, Newell M L. Modelling HIV-RNA viral load in vertically infected children. Stat Med 2004; 23: 769-781. (Pubitemid 38279512)
22. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8: 551-561. (Pubitemid 19116001)
23. Cleves M. An introduction to survival analysis using Stata. College Station, TX, USA: Stata Press, 2004.
24. Boyd K, Dunn D T, Castro H, et al. Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children. AIDS 2010; 24: 1213-1217.
25. Davies M A, Connell T, Johannisen C, et al. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. AIDS 2009; 23: 961-969.
26. Rabie H, Meyer T, Cotton M F. Immune reconstitution infl ammatory syndrome in children. Southern African J HIV Med 2009; 10: 70-75.
27. Ritz N, Tebruegge M, Connell T, et al. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Antimicrob Agents Chemother 2009; 53: 316-318.